Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Hematol., Transfus. Cell Ther. (Impr.) ; 41(4): 292-297, Oct.-Dec. 2019. tab
Article in English | LILACS | ID: biblio-1056243

ABSTRACT

ABSTRACT Introduction: Multiple myeloma (MM) is a common hematologic malignancy with variable degrees of immunodeficiency. Disease- and treatment-related compromise of the immune system predisposes patients to infections, which are a major cause of morbidity and mortality. Objective: We aimed to establish the incidence and main characteristics of infections in MM patients treated at our center over a 10-year period. Method and results: Of the 412 patients retrospectively analyzed, 154 (37.4%) were documented to have at least one episode of infection and were included in this study. A total of 244 infectious episodes were documented. The most common site of infection was the lung, followed by the genitourinary system. The most common infections were bacterial, followed by viral. Escherichia coli were the most common organism. In 160 (65.5%) episodes, the organism was not isolated. Thalidomide with dexamethasone was the most common treatment regimen, followed by melphalan with dexamethasone. Infection was the main cause of death in 26 (6.3%) out of all 412 patients. Conclusion: Infections are a notable cause of morbidity and mortality in the clinical course of MM patients. By considering patient and disease characteristics, a risk-adapted selection of the MM treatment should be employed, with special attention toward patient age and disease-associated organ dysfunction. Patient education, access to healthcare and physician vigilance are also essential. Vaccination and antimicrobial prophylaxis may be considered prior to or during therapy.


Subject(s)
Mortality , Drug Therapy , Infections , Multiple Myeloma/therapy
2.
Indian J Pathol Microbiol ; 2011 Jan-Mar 54(1): 121-123
Article in English | IMSEAR | ID: sea-141930

ABSTRACT

Parasitic gastrointestinal infections are a major cause of morbidity and mortality in the developing world, with stool microscopy being the mainstay of diagnostic practice. Both direct microscopy and concentration techniques can be utilized; direct microscopy may be time consuming and tedious; however clinical laboratories in developing countries lack trained staff who can effectively use concentration methods. In our practice we used the Parasep O and P filter concentrator tubes (manufactured by DiaSys Ltd, Berkshire, England. Product Code 146000) along with direct microscopic techniques and found that Parasep filters enhanced the ability to detect intestinal parasites that would have been missed on routine microscopy. We found the Parasep filter concentration method to be easy, cost-effective and reliable for routine stool examinations.


Subject(s)
Animals , Clinical Laboratory Techniques/economics , Clinical Laboratory Techniques/methods , Feces/parasitology , Humans , Intestinal Diseases, Parasitic/diagnosis , Microscopy , Parasites/isolation & purification , Parasitology/economics , Parasitology/methods , Sensitivity and Specificity , Specimen Handling/economics , Specimen Handling/methods
SELECTION OF CITATIONS
SEARCH DETAIL